Gaudium IVF and Women Health's Q4 FY 2025-26 Quarterly Results

Result Summary

• Gaudium IVF and Women Health Ltd reported a 24.1% quarter-on-quarter (QoQ) increase in its consolidated revenues for the quarter-ended Mar (Q4 FY 2025-26). On a year-on-year (YoY) basis, it witnessed a - of -.
• Its expenses for the quarter were up by 2.3% QoQ and - - YoY.
• The net profit increased 130.3% QoQ and - - YoY.
• The earnings per share (EPS) of Gaudium IVF and Women Health Ltd stood at 1.34 during Q4 FY 2025-26.

Financial Statments for Q4 FY 2025-26

---

Data Source: BSE, Company announcements The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results

Company Overview

Gaudium IVF and Women Health Ltd is a company that primarily operates in the healthcare sector, focusing on fertility solutions and women's health services. The company is known for providing advanced fertility treatments, including in vitro fertilization (IVF), and a range of women's health services designed to support and enhance reproductive health. As of the latest data available up to October 2023, there are no specific recent major developments or announcements regarding the company. Information about their market presence, competitive landscape, or strategic initiatives is not provided within the current scope of data.

Revenue

In the fourth quarter of the fiscal year 2026 (Q4FY26), Gaudium IVF and Women Health Ltd reported a total income of ₹30.53 crores. This represents a substantial increase from ₹24.61 crores in the previous quarter (Q3FY26), marking a quarter-over-quarter growth of 24.1%. The data does not provide figures for Q4FY25, thus a year-over-year comparison is not possible. The notable rise in revenue from Q3FY26 to Q4FY26 highlights a period of increased income, possibly attributable to various factors linked to the company's operational or strategic initiatives within that timeframe.

Profitability

The profit before tax for Q4FY26 was recorded at ₹10.42 crores, compared to ₹4.96 crores in Q3FY26, resulting in a significant quarter-over-quarter growth of 110.1%. The company incurred a tax expense of ₹2.06 crores in Q4FY26, which was higher than the ₹1.33 crores paid in Q3FY26, reflecting a 54.9% increase. Consequently, the profit after tax for Q4FY26 was ₹8.36 crores, up from ₹3.63 crores in Q3FY26, marking a substantial increase of 130.3%. Due to the absence of data for Q4FY25, the year-over-year comparison for profitability metrics is not applicable. Furthermore, the earnings per share for Q4FY26 stood at ₹1.34, significantly higher than the ₹0.59 reported in the preceding quarter, reflecting an increase of 127.1%.

Operating Metrics

The company's total expenses amounted to ₹20.11 crores in Q4FY26, up from ₹19.65 crores in Q3FY26, representing a modest quarter-over-quarter increase of 2.3%. The operating metrics indicate a growing expense base alongside rising revenues. The data does not provide sufficient information to compute key financial ratios such as the P/E ratio, debt-to-equity ratio, or current ratio. However, the available metrics illustrate a financial period characterized by increased expenses, revenue, and profit margins in Q4FY26 in comparison to the previous quarter. Without historical data for Q4FY25, further year-over-year analysis on operating metrics cannot be conducted.